glp-1 and inflammation Glucagon-like peptide-1 receptor: mechanisms advances in therapy GLP-1-based therapies, including GLP-1, GLP-1R
Description
Pancreatic pathophysiology in cystic fibrosis
Enhance personalization with AI-driven nutrition, activity tracking, and behavioral support
The effect sizes were modest (about 2 to 3 percent reduction in body measurements), but statistically significant
PMC 6486297
